You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: December 15, 2025

Details for New Drug Application (NDA): 211857

✉ Email this page to a colleague

« Back to Dashboard

NDA 211857 describes VASOPRESSIN, which is a drug marketed by Am Regent, Amneal, Amphastar Pharms Inc, Cipla, Dr Reddys, Eagle Pharms, Eugia Pharma, Fresenius Kabi Usa, Gland, Baxter Hlthcare Corp, and Long Grove Pharms, and is included in eleven NDAs. It is available from twelve suppliers. There is one patent protecting this drug. Additional details are available on the VASOPRESSIN profile page.

The generic ingredient in VASOPRESSIN is vasopressin. There are nine drug master file entries for this compound. Sixteen suppliers are listed for this compound. Additional details are available on the vasopressin profile page.

Summary for 211857

Tradename:	VASOPRESSIN
Applicant:	Amphastar Pharms Inc
Ingredient:	vasopressin
Patents:	0

Pharmacology for NDA: 211857

Physiological Effect	Decreased Diuresis Vasoconstriction

Suppliers and Packaging for NDA: 211857

Tradename	Generic Name	Dosage	NDA	Application Type	Supplier	National Drug Code	Package Code	Package
VASOPRESSIN	vasopressin	SOLUTION;INTRAVENOUS	211857	ANDA	Amphastar Pharmaceuticals, Inc.	0548-9701	0548-9701-00	1 VIAL in 1 CARTON (0548-9701-00) / 1 mL in 1 VIAL

Profile for product number 001

Active Rx/OTC/Discontinued:	RX	Dosage:	SOLUTION;INTRAVENOUS			Strength	20UNITS/ML (20UNITS/ML)
Approval Date:	Jul 18, 2022	TE:	AP	RLD:	No

Complete Access Available with Subscription

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.